Boston Scientific Corp (MIL:1BSX)
€ 85.5 0 (0%) Market Cap: 126.98 Bil Enterprise Value: 135.61 Bil PE Ratio: 74.26 PB Ratio: 6.39 GF Score: 56/100

Boston Scientific Corp at Wells Fargo Healthcare Conference Transcript

Sep 07, 2022 / 07:10PM GMT
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

Are we live? We're going to get an extra minute. Good afternoon, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. And it is my pleasure to host this session with Boston Scientific. With us, of course, we have Mike Mahoney, the Chairman and CEO; and Lauren Tengler, the Vice President of Investor Relations.

In terms of format, it's going to be a fireside chat. If anyone has a question, just raise your hand. We'll call on you. Mike and Lauren, thanks so much for being here.

Michael F. Mahoney
Boston Scientific Corporation - Chairman, President & CEO

Thank you.

Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

Should we ask for questions now?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot